Given they expect OCC to manufacture the product to supply BioHorizon, you can assume OCC will be compensated for this. They're not going to enter a deal where they're absorbing all the manufacturing costs themselves and run at a loss.
Ann: OCC Signs Striate Global License And Manufacturing Agreement, page-195
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
0.035(6.80%) |
Mkt cap ! $115.2M | |||
| Open | High | Low | Value | Volume |
| 52.5¢ | 55.0¢ | 52.5¢ | $844.3K | 1.568M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14740 | 54.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.0¢ | 74377 | 2 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |